Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7341 p329
19 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Cancer networks should include pharmacy leads

Including pharmacy leads in cancer networks is good practice, according to the National Audit Office’s progress report (PDF 600K) on the NHS Cancer Plan published last week.

Recruiting for such positions is a challenge. Only 12 of the 17 lead pharmacist positions are filled and only eight of those are full time positions.

The NAO concludes that cancer networks are not always as effective as they could be in terms of staffing, cancer services planning or in receiving full support from other parts of the health care system. The NAO judged that, overall, the NHS Cancer Plan was well conceived and that substantial progress had been made to date. The downward trend in mortality rates observed in England is ahead of the Department of Health’s trajectory to achieve the target of a 20 per cent reduction in mortality from cancer in persons under 75 years by 2010.

Tim Root, chairman of the British Onocology Pharmacy Association, commented: “[The report] clearly recognises two key priorities identified by BOPA: development of a robust workforce strategy including education and training, and the establishment of network lead pharmacist posts.”

Back to Top


©The Pharmaceutical Journal